For how we live.
Abilify MyCite embeds a sensor in an antipsychotic tablet to log each dose to an app. Nearly a decade on, its own FDA label still says it has not been shown to improve whether patients take their medicine.
Cobenfy, approved in the US in September 2024, cut symptom scores more than placebo in two five-week trials — without the weight gain and movement effects of older drugs, but with cholinergic side effects.
A matched cohort of 173,910 people with dementia in England tied the drugs to raised risks of pneumonia, stroke, clots, heart attack, fracture and kidney injury — highest just after starting.
A within-individual analysis of 505,474 people in Finland and Sweden found lower psychiatric hospitalisation on clozapine in every disorder studied except borderline personality disorder, with no excess mortality signal.
A 22-year US analysis links hotter months to more overdose deaths. A British Columbia case-control study finds antipsychotic dispensing associated with dying in the 2021 heat dome.